Novavax, Inc.

Gaithersburg, Maryland, United States


Purpose

to evaluate the safety, immunogenicity, and potential efficacy of a candidate vaccine to prevent COVID-19 infection and/or disease in the South African population

Division

Global Health

Date

July 2020

Region Served

AFRICA

Committed amount

$15,000,000

Grant topic

HIV, Pneumonia & Pandemic Preparedness

Duration (months)

22

Grantee location

Gaithersburg, Maryland, United States

Related work

HIV

Pneumonia

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.